[Clinical experience with the systemic administration of clotrimazol. Pharmacokinetics, action, tolerance].
D000935:Antifungal Agents / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D001826:Body Fluids / Q000032:analysis; D002177:Candidiasis / Q000188:drug therapy; D004361:Drug Tolerance; D004696:Endocarditis / Q000188:drug therapy; D006505:Hepatitis / Q000378:metabolism; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D007674:Kidney Diseases / Q000378:metabolism; D007700:Kinetics; D008103:Liver Cirrhosis / Q000378:metabolism; D008172:Lung Diseases, Fungal / Q000188:drug therapy; D009181:Mycoses / Q000188:drug therapy; D012463:Saliva / Q000378:metabolism; D018805:Sepsis / Q000188:drug therapy; D013183:Sputum / Q000032:analysis; D014552:Urinary Tract Infections / Q000188:drug therapy
D000935:Antifungal Agents; D001555:Benzene Derivatives; D007093:Imidazoles
Klinische Erfahrungen mit der systemischen Verabreichung von Clotrimazol. Pharmakokinetik, Wirkung, Verträglichkeit